solnatide
Peptideexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2012 (NCT01627613)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
SCNN1A activator
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297885 ↗
Also known as
- ap301
- ap301
- ap-301
- ap-301
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03567577 | Phase 2 | May 23, 2018 | Apeptico Forschung und Entwicklung GmbH |
| NCT02095626 | Phase 2 | Jun 1, 2013 | Apeptico Forschung und Entwicklung GmbH, University of Vienna |
| NCT01627613 | Phase 2 | Jul 1, 2012 | Apeptico Forschung und Entwicklung GmbH, University of Vienna |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Apeptico Forschung und Entwicklung GmbH | For profit | 3 | 3 | 1 | 2012 |
| University of Vienna | Academic/Hospital | 2 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1